AI assistant
Sending…
Vicore Pharma Holding — Major Shareholding Notification 2019
Nov 14, 2019
3211_iss_2019-11-14_c1c663a6-c715-4b08-ada3-0c56c4c63080.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Vicore Pharma Holding AB
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | 2,060,000 |
| Voting rights | 2,060,000 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 13/11/2019 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 3,210,000 |
| Directly held voting rights | 3,210,000 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 6.4 % |
| Directly held voting rights | 6.4 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 6.4 % | 3,210,000 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 6.4 % | 3,210,000 |
| Group total holdings |
||
| Voting rights 3,210,000 Percentage of voting rights 6.4 |
||
| Published 14/11/2019 09:47 |
||
| Contact | ||
| Name Jannis Kitsakis |
||
| Phone 070-6038023 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Vicore Pharma Holding
Major Shareholding Notification
2026
May 11
AGM Information
2026
May 6
AGM Information
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Annual Report
2026
Mar 26
Share Issue/Capital Change
2025
Nov 28
Share Issue/Capital Change
2025
Nov 28
Major Shareholding Notification
2025
Nov 27
Major Shareholding Notification
2025
Nov 14